Innoviz COO granted RSUs and stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Innoviz Technologies reported that Chief Operating Officer Ido Luski received new equity awards on August 4, 2026. He was granted 64,688 Restricted Share Units and share options for 69,296 ordinary shares at a 0.4200 per-share exercise price, both vesting one-fourth on August 4, 2027 and quarterly thereafter through 2030, subject to continued service. Following these awards, he directly owns 393,701 ordinary shares, including shares underlying RSUs.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option F4 | 69,296 | $0.00 | $0.00 |
| Grant/Award | Ordinary Shares F1, F2, F3 | 64,688 | $0.00 | $0.00 |
Footnotes (4)
- F1. Represents 64,688 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.
- F2. Includes 230,260 ordinary shares issuable upon vesting of RSUs; of which (a) 1,949 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 8,304 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 9,803 RSUs granted February 27, 2024, with 1,956 vesting quarterly through 2027 and 7,847 vesting quarterly through 2028; (d) 19,089 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 13,343 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 66,252 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 46,832 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 64,688 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.
- F3. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
- F4. Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
Key Figures
Key Terms
exercise price financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Innoviz Technologies (INVZ) grant to COO Ido Luski?
What are the vesting terms of the new RSUs granted to Innoviz (INVZ) COO?
What are the vesting and expiration terms of Ido Luski’s new Innoviz (INVZ) stock options?
What conditions apply to the vesting of Innoviz (INVZ) COO’s RSUs and options?
AI-generated analysis. How Rhea-AI works. Not financial advice.